Annual report pursuant to Section 13 and 15(d)

QUARTERLY FINANCIAL DATA (UNAUDITED)

v3.6.0.2
QUARTERLY FINANCIAL DATA (UNAUDITED)
 12 Months Ended
Dec. 31, 2016
Quarterly Financial Information Disclosure [Abstract]  
QUARTERLY FINANCIAL DATA (UNAUDITED)
QUARTERLY FINANCIAL DATA (UNAUDITED)
 
Quarterly financial data for 2016 and 2015 was as follows:
 
 
Three Months Ended
2016
 
March 31,
 
June 30,
 
September 30,
 
December 31,
 
 
(In millions, except per share data)
Operating revenue
 
$
728.3

 
$
811.3

 
$
804.1

 
$
801.1

Operating income
 
$
176.2

 
$
225.7

 
$
212.1

 
$
203.9

Consolidated net income
 
$
102.4

 
$
133.0

 
$
134.9

 
$
124.8

Net income attributable to Equifax
 
$
102.1

 
$
130.9

 
$
132.8

 
$
123.0

Basic earnings per share*
 
 

 
 

 
 

 
 

Net income attributable to Equifax
 
$
0.86

 
$
1.10

 
$
1.11

 
$
1.03

Diluted earnings per share*
 
 

 
 

 
 

 
 

Net income attributable to Equifax
 
$
0.85

 
$
1.08

 
$
1.09

 
$
1.01

 
 
 
Three Months Ended
2015
 
March 31,
 
June 30,
 
September 30,
 
December 31,
 
 
(In millions, except per share data)
Operating revenue
 
$
651.8

 
$
678.1

 
$
667.4

 
$
666.3

Operating income
 
$
154.2

 
$
188.5

 
$
174.3

 
$
176.9

Consolidated net income
 
$
89.6

 
$
112.5

 
$
119.7

 
$
113.0

Net income attributable to Equifax
 
$
88.3

 
$
111.0

 
$
117.9

 
$
111.9

Basic earnings per share*
 
 

 
 

 
 

 
 

Net income attributable to Equifax
 
$
0.74

 
$
0.94

 
$
1.00

 
$
0.94

Diluted earnings per share*
 
 

 
 

 
 

 
 

Net income attributable to Equifax
 
$
0.73

 
$
0.92

 
$
0.98

 
$
0.93


* 
The sum of the quarterly EPS does not equal the annual EPS due to changes in the weighted-average shares between periods. Other amounts may not equal the annual total due to rounding between periods.
 
The comparability of our quarterly financial results during 2016 and 2015 was impacted by certain events, as follows:
 
•
For the year ended December 31, 2016, we recorded $40.2 million ($28.2 million, net of tax) for Veda acquisition related amounts. Of this amount, $30.1 million relates to transaction and integration costs in operating income, $9.2 million is recorded in other income and is the impact of foreign currency changes on the transaction structure, including the economic hedges, and $0.7 million is recorded in interest expense. See Note 3 of the Notes to Consolidated Financial Statements.

•
During Q1 2015, we recorded a $20.7 million restructuring charge ($13.2 million, net of tax) all of which was recorded in selling, general and administrative expenses on our Consolidated Statements of Income. See Note 12 of the Notes to Consolidated Financial Statements.

•
During Q2 2015, we recorded a 46.0 million Brazilian Reais ($14.8 million) impairment of our investment in BVS. See Note 2 of the Notes to Consolidated Financial Statements.